Table 2 Implementation evaluation domains, outcomes measures, and data sources
RE-AIM Domain | Outcome measure | Sample | Data source |
|---|---|---|---|
Reach | % screened with PHQ-2 | All adult clinic patients | Routine data abstraction (Triage Book) |
% screened positive (PHQ-2 > 2) | All adult clinic patients | Routine data abstraction (Triage Book) | |
Accuracy of positive screens assessed with PHQ survey data from patient longitudinal cohort | |||
% positive screens who receive further evaluation (PHQ-9/MINI) | Patient cohort | Routine data abstraction (clinic charts) | |
% positive screens who are depressed (PHQ-9 > 9) | Patient cohort | Routine data abstraction (clinic charts) | |
Accuracy of provider PHQ-9 assessed with PHQ survey data | |||
% depressed who receive antidepressants (treatment uptake) | Patient cohort subset (baseline PHQ-9 > 9) | Routine data abstraction (Depression Treatment Registry) | |
Adoption | Provider knowledge, attitudes and practices regarding depression care | Provider cohort | Provider survey data |
Implementation quality (fidelity) | Initial prescription: Appropriate diagnosis, treatment prescription (medication and dose) | Clinic level data | Supervision log data (aggregate data from monthly chart reviews of newly prescribed patients) |
Treatment management: Appropriate assessment of symptoms, side effects, and prescription (medication and dose) | Clinic level data | Supervision log data (aggregate data from monthly chart reviews of ongoing treatment patients) | |
Effectiveness | Alleviation of depression | Patient cohort subset (baseline PHQ-9 > 9) | Patient PHQ-9 survey data |
Improvement in condom use, work status and ART adherence | Patient cohort subset (baseline PHQ-9 > 9) | Patient survey data |